A Phase I Study of a Novel BCMAxCD3 Bispecific Antibody Emb-06 in Relapsed or Refractory Multiple Myeloma

被引：0

作者：

Tan, Peter ^{[1
]}

Bao, Li ^{[2
]}

Yin, Qingsong ^{[3
]}

Li, Chunrui ^{[4
]}

Shavaksha, Sorab Jehangir ^{[5
]}

Prince, H. Miles ^{[6
,7
]}

Cai, Zhen ^{[8
]}

Gao, Shan ^{[9
]}

Wang, Qian ^{[3
]}

Wang, Di ^{[4
]}

Li, Yi ^{[10
]}

Zhang, Mingfei ^{[11
]}

Deng, Qiumei ^{[12
]}

Lu, Qiaoyang ^{[11
]}

Jiang, Chengjun ^{[11
]}

Ren, Fang ^{[11
]}

Wu, Danqing ^{[11
]}

Zeng, Shuqi ^{[11
]}

Zhu, Yonghong ^{[11
]}

Tao, Yi ^{[13
]}

Liu, Yuanfang ^{[13
]}

Mi, Jian-Qing ^{[13
]}

机构：

[1] Linear Clin Res, Nedlands, Australia

[2] Beijing Jishuitan Hosp, Beijing, Peoples R China

[3] Zhengzhou Univ, Henan Canc Hosp, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China

[5] Sunshine Coast Radiol, Buderim, Qld, Australia

[6] Epworth Healthcare, Melbourne, Vic, Australia

[7] Univ Melbourne, Melbourne, Australia

[8] First Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China

[9] Beijing Jishuitan Hosp, Beijing, Peoples R China

[10] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China

[11] Shanghai EpimAb Biotherapeut, Shanghai, Peoples R China

[12] EpimAb Biotherapeut, Shanghai, Peoples R China

[13] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol,State Key Lab Med Genom, Natl Res Ctr Translat Med Shanghai,Sch Med, Shanghai, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-193738

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：499 / 499

页数：1